We are live on ! Find out more
AT

Arvest Trust Portfolio holdings

AUM $1.68B
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+14.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$915M
AUM Growth
+$41.4M
Cap. Flow
-$10.8M
Cap. Flow %
-1.18%
Top 10 Hldgs %
38.19%
Holding
112
New
13
Increased
21
Reduced
56
Closed
5

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.7M
2
GILD icon
Gilead Sciences
GILD
+$13.8M
3
WMT icon
Walmart Inc
WMT
+$10.2M
4
COP icon
ConocoPhillips
COP
+$1.07M
5
XOM icon
ExxonMobil
XOM
+$310K

Sector Composition

Rank Sector Weight
1 Healthcare 11.77%
2 Technology 11%
3 Financials 8.61%
4 Energy 7.98%
5 Consumer Staples 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
76
Enterprise Products Partners
EPD
$82.3B
$217K 0.02%
7,118
MMM icon
77
3M
MMM
$90.9B
$206K 0.02%
+2,063
New +$201K
CSX icon
78
CSX Corp
CSX
$93.4B
$204K 0.02%
+23,742
New +$199K
SO icon
79
Southern Company
SO
$109B
$204K 0.02%
4,965
-172
-3% -$7.41K
TAT
80
DELISTED
TransAtlantic Petroleum LTD.
TAT
$125K 0.01%
14,900
CIM
81
Chimera Investment
CIM
$1.04B
$33K ﹤0.01%
+733
New +$32.6K
BAC icon
82
Bank of America
BAC
$435B
-13,600
Closed -$175K
DUK icon
83
Duke Energy
DUK
$97.8B
-3,391
Closed -$229K
OKS
84
DELISTED
Oneok Partners LP
OKS
-5,370
Closed -$266K

Similar funds

Arvest Trust's Q3 2013 Portfolio in Review

As of Q3 2013, Arvest Trust held 112 positions worth $915M, up 4.7% from $873M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Arvest Trust's Q3 2013 filing shows 13 new, 21 increased, 56 reduced and 5 closed positions. Its largest new stake was Allergan plc: 122,320 shares worth $17.7M. The largest sale was Biogen, an estimated $16.7M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.

  • Arvest Trust's largest Q3 2013 buy was Allergan plc: 122,320 shares worth $17.7M.
  • Arvest Trust added most to iShares MSCI EAFE ETF in Q3 2013, an estimated $1.34M increase.
  • Arvest Trust's biggest Q3 2013 reduction was Biogen, cutting an estimated $16.7M.
  • Arvest Trust fully exited Oneok Partners LP in Q3 2013, selling an estimated $266K.
  • Arvest Trust's ten largest holdings make up 38% of its $915M portfolio in Q3 2013.
  • Arvest Trust opened 13 new positions and closed 5 in Q3 2013.
  • Arvest Trust's portfolio value rose 4.7% quarter-over-quarter to $915M.

Based on Arvest Trust's 13F filing for Q3 2013, filed 21 Nov 2013.